BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
VANCOUVER, BC , May 29, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizon Technology Finance Corporation ("Horizon") have executed a follow-on Amendment ("Amendment") to the Asset Purchase Agreement dated February 11th, 2024 ("APA") for acquiring the entire portfolio of assets and intellectual property based on the DPX™ immune educating platform technology developed by Canadian biotechnology company, IMV Inc.
Section 12 of the February 11 th, 2024 APA is a performance milestone provision for BioVaxys to demonstrate an aggregate capital raise of USD $10M by December 31 , 2024. On December 9 th, 2024, Horizon and BioVaxys initially amended the APA by agreeing to delete the reference to " December 31, 2024 " found in Section 12 and replacing it with the date of " June 30, 2025 ."
This new Amendment of May 29 th, 2025, supersedes and replaces the Section 12 terms of the APA so that the net performance milestone required to be raised in any form (including, but not limited to equity, grants, licensing fees, or loans) is now significantly lowered to USD $2,028,636 . If BioVaxys is successful in meeting this milestone by September 30, 2025 , Section 12 of the APA shall end and be of no further force or effect.
As consideration for Horizon amending the APA, BioVaxys agrees to issue to Horizon 2,800,000 share purchase warrants and 1,200,000 share purchase warrants to Powerscourt Investments XXV LP ("Powerscourt"), with each warrant entitling Horizon and Powercourt the purchase of one whole at a purchase price of $0.06 Canadian Dollars per share at any time on or before May 31 , 2028. Horizon and Powerscourt are the members/owners of HIMV LLC (70%/30%), the party to the APA. All other terms and conditions of the APA to remain the same.
BioVaxys and Horizon have further agreed that Section 7(c)(i) of the APA "Licensing Earn-Out Payments Term" be amended from the original "Eighth anniversary of the Closing Date" found in the last line of Section 7(c)(i) to August 11, 2033. During the Licensing Non-Sales Earn-Out Term, BioVaxys shares a predetermined percentage of net licensing non-sales revenues with Horizon.
The "Licensing Non-Sales Earn-Out Term" refers to payments received from an existing licensee or preexisting potential licensee, ending upon the expiration of the last valid claim of a former IMV patent that is the subject of the license agreement to which such existing licensee or preexisting potential licensee is party, and any other payment received under a license agreement, ending on August 11, 2033 .
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com) is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on its DPX™ immune-educating technology platform and its HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergy, and other immunological diseases. Through a differentiated and unique mechanism of action, the DPX™ platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. The Company's clinical stage pipeline includes maveropepimut-S (MVP-S), based on the DPX™ platform, in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers, and also delivers an innate immune activator and a universal CD4 T cell helper peptide. MVP-S has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. BioVaxys is also developing DPX™+SurMAGE, a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV for Respiratory Syncytial Virus, and DPX+rPA for peanut allergy prophylaxis, as well as several viral vaccines. BioVaxys has licensed its patented liposome-based delivery platform to Zoetis, Inc. and SpayVac-for-Wildlife, Inc. for selected animal health applications.
BioVaxys common shares are listed on the CSE under the stock symbol 'BIOV', trade on the Frankfurt Bourse (FRA: 5LB), and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed " James Passin "
James Passin , Chief Executive Officer
Phone: +1 740 358 0555
Cautionary Statements Regarding Forward Looking Information
This press release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein, without limitation, statements relating the future operating or financial performance of the Company, are forward looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements.
These forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies including, primarily but without limitation, the risk that BioVaxys' vaccines will not prove to be effective and/ or will not receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about whether its products will complete the long, complex and expensive clinical trial and regulatory approval process for approval of new drugs necessary for marketing approval, and, if so, whether its vaccine products will be commercially accepted and profitable, the expenses, delays and uncertainties and complications typically encountered by development stage biopharmaceutical businesses, financial and development obligations under license arrangements in order to protect its rights to its products and technologies, obtaining and protecting new intellectual property rights and avoiding infringement to third parties and their dependence on manufacturing by third parties.
The Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Investors are encouraged to read BioVaxys continuous disclosure documents and audited annual consolidated financial statements which are available on SEDAR at www.sedar.com.
Logo - https://mma.prnewswire.com/media/1430981/5345338/BIOVAXYS_Logo.jpg
SOURCE BioVaxys Technology Corp.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
MARBLEX'S NEW TOY-INSPIRED PIXEL RPG META TOY DRAGONZ SAGA SURPASSES 500,000 GLOBAL PRE-REGISTRATIONS
SEOUL, South Korea, Aug. 21, 2025 /CNW/ -- Blockchain gaming company MARBLEX announced that its upcoming pixel art collectible RPG Meta Toy Dragonz Saga has surpassed 500,000 global pre-registrations, signaling strong anticipation ahead of its official launch later this month. Developed by Sandbox Network and published through MARBLEX's innovative Web3 Publishing Model, Meta Toy Dragonz Saga combines nostalgic pixel art with modern blockchain elements, offering players over 300 unique "Toy Dragons" to collect, train, and battle. Pre-registration is now open on both the Google Play Store and Apple App Store, with global launch scheduled for the end of August. Earlier this year, MARBLEX unveiled its 2025 Roadmap under the slogan FUN COMES FIRST. As part of this initiative, the company introduced its Web3 Model—an evolved approach that goes beyond simple game onboarding. This model emphasizes in-depth evaluation, close collaboration with developers, customized blockchain and business model design, one-stop integration, and robust marketing support. Backed by a joint fund of over USD 20 million with Immutable, MARBLEX reinvests revenue share fees into its ecosystem to drive token value, foster community growth, and accelerate the expansion of its Web3 gaming lineup. Building on the momentum of Self-made Billionaire: Stock Game and Meta Toy Dragonz Saga, MARBLEX is preparing to onboard additional titles in the second half of 2025, including Dice Go! (Real-time Monopoly PvP) and Kritika (ARPG). More information can be found on the MARBLEX's official website, Medium, Telegram, and X. MARBLEX is a blockchain-powered subsidiary of Netmarble Corp. Netmarble Corp. is a well-established developer and publisher of mobile games composed of more than 6,000 game industry veterans and blockchain technology experts from across the globe. MARBLEX aims to bring the highest quality blockchain games to market by providing key services such as a cryptocurrency wallet, decentralized exchange, token staking, and an NFT Marketplace. MBX, a proprietary blockchain ecosystem launched by MARBLEX, allows gamers to advance their experiences through organic engagement and rewards for participation. The MBX ecosystem can be enjoyed as part of popular Netmarble titles, such as Meta World: My City, A3: Still Alive and Ni no Kuni: Cross Worlds.
Cision Canada
2 hours ago
- Cision Canada
US Drone Land Surveying Market Projected to Reach $14 Billion By 2030 as Government Uses Increase
NEW YORK, /CNW/ -- The land surveying market is being revitalized by the emergence of drone technology, offering a more efficient, accurate, safer, and cost-effective approach to data collection and analysis. Industry insiders are saying that in recent years, drone land surveying has become a groundbreaking solution for professionals in land assessment, mapping, and surveying industries. By leveraging UAV technology, land surveyors can now complete projects faster, more efficiently, and with a level of precision previously unattainable using traditional methods. Unlike conventional techniques, drones provide quick data collection with minimal human intervention, enhancing productivity while reducing costs. This new wave of innovation is transforming industries such as construction, agriculture, and environmental management. The integration of UAV technology allows surveyors to gather aerial imagery in real-time, generating highly detailed and accurate maps for topographic mapping and other vital surveying applications. As this technology evolves, the demand for more sophisticated data analysis and quicker survey turnaround times continues to rise. By embracing drones, land surveyors can now offer services that were previously time-consuming and expensive. With drones in the field, traditional surveying methods are quickly becoming a thing of the past, making way for the future of land surveying." Active Companies in the Drone Industry today include ZenaTech, Inc. (NASDAQ: ZENA), Draganfly Inc. (NASDAQ: DPRO), AgEagle Aerial Systems Inc. (NYSE: UAVS), Lantronix Inc. (NASDAQ: LTRX), Red Cat Holdings Inc. (NASDAQ: RCAT). GOOGLE AI searches say that the global drone surveying and mapping service market was valued at USD 1.42 billion in 2024 and is projected to reach USD 6.7 billion by 2035, growing at a CAGR of 17.1%; and the US drone land surveying market alone is projected to grow significantly, reaching an estimated value of USD 14.55 billion by 2030. According to "The core of UAV drone land surveying is the combination of sophisticated aerial systems and powerful software that work together to collect, process, and analyze data. Surveying drones equip high-definition cameras, LiDAR sensors, and other advanced technologies, enabling precise geospatial analysis. These aerial systems capture aerial imagery from multiple angles, enabling the creation of detailed 2D and 3D models of the surveyed area. The software used alongside drones plays a critical role in the processing and analysis of collected data. Surveying software enables professionals to stitch images together, process LiDAR point clouds, and generate accurate topographic maps. The integration of UAV technology with mapping software ensures that the collected data is processed quickly, accurately, and in real-time." ZenaTech (NASDAQ:ZENA) Signs Agreements to Acquire Two Florida Companies, Expanding Drone as a Service Footprint into Aviation, Defense, and Power Washing - ZenaTech, Inc. (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces it has signed offers to acquire two Florida-based companies expected to expand its US DaaS services footprint into drone-based power washing and new aviation, defense, government, and commercial customers. The acquisitions will unlock significant revenue potential as well as diversification across the Southeast region and nationally. One proposed acquisition is a Florida-based power wash services company with operations across multiple counties, marking ZenaTech's first US entry into the power washing sector. This acquisition will provide ZenaTech with a platform to scale drone-enabled power wash services rapidly to new markets, including airplane maintenance, aviation facilities, and defense infrastructure. Power washing in aviation uses high-pressure water and drone-assisted cleaning systems to remove dirt, debris, and contaminants from aircraft exteriors and infrastructure, and cleans and sanitizes interiors. The sector is poised to grow due to increasing fleet sizes, stricter safety and efficiency standards, and the rising adoption of automated, eco-friendly maintenance technologies. An additional proposed acquisition is a land surveying firm with over 30 years of history serving Florida-based developers and homebuilders. With a long-standing client base and trusted reputation, the Company believes this partnership will enhance its Southeast region DaaS presence and create a strong platform to expand drone services across additional construction and real estate customers, further consolidating the company's regional footprint. "When finalized, these acquisitions will provide diversification and future revenue streams for Drone as a Service across our Southeast and national networks," said Shaun Passley, Ph.D., ZenaTech CEO. "Expanding our reach to aviation and defense is strategic as we believe the future of aviation maintenance is autonomous. By replacing ladders, scaffolding, and chemical-heavy processes with smart cleaning drones, for both interior and exteriors of planes, we hope to help airlines and defense operators set a new standard for safety, sustainability, and efficiency." ZenaTech has closed eight US acquisitions toward its goal of establishing 25 Drone as a Service locations across the US by mid-2026. The company's DaaS model is designed to provide flexible, on-demand access to drone services for surveying, inspections, maintenance, power washing, precision agriculture and more, eliminating the need to have to invest in drone hardware and software, worry about maintenance, regulatory compliance, or finding pilots. The company's strategy is aimed at acquiring established land survey engineering firms, and other old-tech or manual service businesses that are ripe for drone innovation, to advance its national vision for a scalable, tech-enabled multiservice drone business anchored by existing customers, recurring revenue, and new growth opportunities. Continued… Other developments in the drone/UAV industries include: Draganfly Inc. (NASDAQ: DPRO) an award-winning, industry-leading drone solutions and systems developer, recently announced its second quarter financial results. Key Financial and Operational Highlights for Q2 2025 were: Revenue for the second quarter of 2025 was $2,115,255 which represents a 22.1% year over year increase. Product sales of $1,901,585 were up 37.1% over the same period last year. Gross profit for Q2 2025 was $504,592 up 9.3% from $461,673 for the same period last year. Gross margin percentage for Q2 2025 was 23.9% compared to 26.6% in Q2 2024. Gross profit would have been $515,013 and gross margin would have been 24.3%, not including a one-time non-cash recovery of a write down of inventory of $10,421. The decrease is due to the sales mix of the products sold. The comprehensive loss for the period of $4,749,634 includes non-cash changes comprised of a negative change in fair value derivative of $180,318, a write down of inventory of $10,421, and an impairment gain on notes receivable of $8,233 and would otherwise be a comprehensive loss of $4,567,128 vs an adjusted comprehensive loss of $4,362,944 for the same period last year. Contributors to the year-over-year increase are increased office and miscellaneous, employee and management expenses, and share based payments, offset by professional fees. Cash balance on June 30, 2025 of $22,571,059 compared to $6,252,409 on December 31, 2024. AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, recently announced their partner in Colombia, Drummond Ltd., a leader in mining sector innovation, was granted multiple certifications for advanced drone operations in-country by the Civil Aeronautics Authority (CAA) in Colombia. The CAA authorizations cover BVLOS (Beyond Visual Line of Sight), night flights, and multi-drone operations (One-to-Many) for Drummond, using the eBee X drone. "We are very proud of Drummond's new levels of certification which result in greater operational capabilities," said Bill Irby, CEO of AgEagle. "Their commitment to expanding what is possible with unmanned systems using the eBee X drone represent a significant step forward in the control, safety, and oversight of Colombian airspace, as well as enhanced safety and efficiencies in their mining operations." Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, recently announced that its TAA- and NDAA-compliant solution was selected by Teal Drones, a Red Cat Holdings Inc. (NASDAQ: RCAT) company, for production of its Black Widow™ drones under the U.S. Army's Short-Range Reconnaissance (SRR) Program. Lantronix has already initiated production shipments, providing early revenue visibility and underscoring Lantronix's role as a trusted technology partner for mission‑critical defense applications. The Lantronix solution, based on the Qualcomm® Dragonwing™ QRB5165 processor, delivers advanced Edge AI processing while meeting stringent U.S. security requirements, enabling full TAA and NDAA compliance for deployment in sensitive Department of Defense (DoD) missions. The combination of AI performance and compliance creates a sustainable advantage for Lantronix in the rapidly expanding defense and autonomous systems market. As part of a select group of Blue UAS-approved small Unmanned Aerial Systems (sUAS) vendors, Teal Drones must meet rigorous cybersecurity, operational and safety standards for DoD use. Lantronix's compliant solution enables Teal to meet these requirements, positioning its Black Widow drones for deployment in frontline missions. DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU'S market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated fifty one hundred dollars for news coverage of the current press releases issued by ZenaTech, Inc. by the Company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Toronto Star
3 hours ago
- Toronto Star
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced that its AirTouch™ N30i nasal cradle mask won two prestigious Red Dot Awards: Product Design 2025 in both the Innovative Products and Medical Design & Healthcare categories. The AirTouch N30i features Resmed's first-ever nasal cushion made from fabric fused with silicone, designed to deliver both clinical performance and a therapy experience that feels more natural and comfortable making it easier for people to start and stick with CPAP therapy. Launched in October 2024, the AirTouch N30i builds on Resmed's legacy of product leadership. The mask combines Resmed's patented ComfiSoft™ fabric cushion and a fabric-wrapped frame designed to deliver softness and breathability without sacrificing performance. Its layered design is intended to help release heat and moisture while maintaining a secure seal for effective therapy. As part of Resmed's Freedom category, it also features a top-of-head hose connection and 360-degree rotating elbow to give users more freedom of movement during sleep.
